Xiaochun Li

机构：Indiana University School of Medicine, Indiana University – Purdue University Indianapolis · ORCID：0000-0003-1109-6119

发表论文 100 篇 · 总被引 2314 次 · h-index 15

代表论文

• Interleukin-6 receptor blockade with tocilizumab to reduce immune-related toxicity with ipilimumab and nivolumab in metastatic melanoma. (2024 · Journal of Clinical Oncology · 被引 21)
• Inflammation preservation strategy: reconciling pain control and disc resorption in lumbar disc herniation (2025 · Frontiers in Immunology · 被引 10)
• A phase II study of the interleukin-6 (IL-6) receptor blocking antibody sarilumab (Sari) in combination with ipilimumab (Ipi), nivolumab (Nivo) and relatlimab (Rela) in patients with unresectable stage III or stage IV melanoma. (2025 · Journal of Clinical Oncology · 被引 8)
• Optimal virtual monoenergy for the detection of pancreatic adenocarcinoma during the pancreatic parenchymal phase on photon counting CT (2025 · Abdominal Radiology · 被引 8)
• Oxidative stress model of lipopolysaccharide combined with thrombin inducing in broiler chicks (2024 · Frontiers in Veterinary Science · 被引 7)
• Patient Comments and Patient Experience Ratings Are Strongly Correlated With Emergency Department Wait Times (2024 · Quality Management in Health Care · 被引 7)